Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 249

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 7
Chunk 249
---
 March 26, 2025. Does    
      not include 1,937,400 ordinary shares issuable upon exercise of outstanding options that are not exercisable within 60 days of March 26,
                                                                       2025.                                                                  
----------------------------------------------------------------------------------------------------------------------------------------------

(8)                     Includes 2,366,400 ordinary shares issuable upon exercise of outstanding options currently exercisable                 
      or exercisable within 60 days of March 26, 2025. Does not include 1,937,400 ordinary shares issuable upon exercise of outstanding options
                                              that are not exercisable within 60 days of March 26, 2025.                                       
-----------------------------------------------------------------------------------------------------------------------------------------------

(9)                                    Includes 342,600 ordinary shares issuable upon exercise of outstanding                                
      options currently exercisable or exercisable within 60 days of March 26, 2025. Does not include 1,712,400 ordinary shares issuable upon
                             exercise of outstanding options that are not exercisable within 60 days of March 26, 2025.                      
---------------------------------------------------------------------------------------------------------------------------------------------

(10)                                           Includes 171,600 ordinary shares and 15,994,800 ordinary                                       
            shares issuable upon exercise of outstanding options and PSUs currently exercisable or exercisable within 60 days of March 26,    
       2025. Does not include 6,006,000 ordinary shares issuable upon exercise of outstanding options and PSUs that are not exercisable within
                                                              60 days of March 26, 2025.                                                      
----------------------------------------------------------------------------------------------------------------------------------------------

(11)                 Includes 329,400 ordinary shares and 3,949,800 ordinary shares issuable upon exercise of outstanding options              
       and PSUs currently exercisable or exercisable within 60 days of March 26, 2025. Does not include 1,441,200 ordinary shares issuable upon
                         exercise of outstanding options and PSUs that are not exercisable within 60 days of March 26, 2025.                   
-----------------------------------------------------------------------------------------------------------------------------------------------

(12)                 Includes 66,600 ordinary shares and 4,109,400 ordinary shares issuable upon exercise of outstanding options               
       and PSUs currently exercisable or exercisable within 60 days of March 26, 2025. Does not include 1,441,200 ordinary shares issuable upon
                         exercise of outstanding options and PSUs that are not exercisable within 60 days of March 26, 2025.                   
-----------------------------------------------------------------------------------------------------------------------------------------------

(13)